ANIK — Anika Therapeutics Share News
0.000.00%
Last trade - 00:00- $191.87m
- $150.85m
- $112.82m
Anika Therapeutics Inc reports results for the quarter ended in March - Earnings Summary
Brief: Anika Therapeutics Q1 Adjusted Earnings Per Share $0.06
Brief: Anika Therapeutics Reports Q4 2020 Financial Results
Brief: Anika Reports Q3 Loss Per Share $0.45
Brief: Anika Announces FDA 510(K) Clearance For Its Wristmotion Total Arthroplasty System
Brief: Anika Announces Appointment Of Jack Henneman And Stephen Richard To Board Of Directors
Brief: Anika Appoints Michael Levitz As Chief Financial Officer
Brief: Anika Therapeutics Says Q2 Revenue Rose 1 Percent To $30.7 Million
Brief: Anika To Launch Six FDA-Cleared Sports Medicine And Extremities Products In Q3
Brief: Anika Announces Planned CFO Transition
Brief: Anika Names Cheryl R. Blanchard As President And CEO
Brief: Anika Therapeutics Says Drawing Down $50 Mln On Existing Credit Facility
Nasdaq Trade Halt Market Wide Circuit Breaker Halt: LEVEL 1 AT 08:38 AM
Brief: Anika Reports Q4 Earnings Per Share $0.28
Brief: Anika Therapeutics Names Dr. Cheryl Blanchard As Interim CEO
Brief: Anika Therapeutics Says CEO Joseph Darling Passed Away On January 29
NASDAQ RESUMED AT 05:00 PM
NASDAQ TRADE HALT HALT NEWS PENDING AT 04:25 PM
Brief: Primo Medical Group Announces Sale Of Its Spin-Off Co Arthrosurface, To Anika Therapeutics